Neoadjuvant immunotherapy and chemoimmunotherapy for stage II-III muscle invasive bladder cancer

OBJECTIVE: Considering the striking evidence revealed by immunotherapy in advanced or metastatic bladder cancer, investigators have explored neoadjuvant immunotherapy and chemoimmunotherapy in muscle-invasive bladder cancer (MIBC). Currently, there have been a large number of studies reporting varie...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hualin, Yang, Wenjie, Xue, Xiaoqiang, Li, Yingjie, Jin, Zhaoheng, Ji, Zhigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428578/
https://www.ncbi.nlm.nih.gov/pubmed/36059550
http://dx.doi.org/10.3389/fimmu.2022.986359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428578/
https://www.ncbi.nlm.nih.gov/pubmed/36059550
http://dx.doi.org/10.3389/fimmu.2022.986359

Ejemplares similares